SOURCE: Solos Endoscopy, Inc.

January 05, 2007 12:16 ET

Solos Endoscopy, Inc. Restructures for Continued Growth and Positions Itself for Earnings

BOSTON, MA -- (MARKET WIRE) -- January 5, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) announced today that it will be undertaking a capital restructuring to better position the Company for growth and expansion. For all shareholders of record as of January 15, 2007, Solos Endoscopy will be implementing a 1 for 100 reverse stock split.

The Solos Endoscopy Board of Directors approved this capital restructure as a means to position the Company to be more attractive for possible acquisition candidates, to reduce the market volatility that Solos Endoscopy shares have experienced, and to better reflect our earnings as compared to other companies in the medical equipment market.

Solos Endoscopy, Inc. recently announced that the Company is offering a share buyback program to its shareholders. Solos Endoscopy, Inc. will offer to buy back common shares of stock from shareholders in exchange for preferred convertible stock to be valued at $0.50 a share. Current shareholders must have their shares into Florida Atlantic Stock Transfer by January 12, 2007 in order to qualify for the exchange of common shares to convertible preferred shares.

For every one share of Solos Endoscopy, Inc. that shareholders turn into Florida Atlantic Stock Transfer by the deadline, the shareholders will receive one share of preferred convertible stock valued at $0.50 per share. The preferred shares, following a one-year holding period, can then be converted back to restricted common shares at a $1.00 for $1.00 exchange. Shareholders must turn in a minimum of 1000 shares in order to qualify. Shareholders must be of record as of December 20, 2006 and must turn in a minimum of 1000 shares in order to qualify.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information